Axia Life Sciences LLP
About Axia Life Sciences LLP
Data last updated:
Axia Life Sciences LLP is a limited liability partnership (LLP) based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 April 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAO-8576.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Vamshidhar Kandlakunta and Lalith Mohan Nudurupati.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at H. No. 1 – 2 – 10/4/503 Evr Shradha Enclave Kakatiya Nagar Street No 2 Habsiguda, Hyderabad, Telangana, India – 500007.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. 1 – 2 – 10/4/503 Evr Shradha Enclave Kakatiya Nagar Street No 2 Habsiguda, Hyderabad, Telangana, India – 500007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Axia Life Sciences LLP FY 2025 filings available
Financial Statement Summary of Axia Life Sciences LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Axia Life Sciences LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Axia Life Sciences are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Axia Life Sciences LLP
Axia Life Sciences has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vamshidhar Kandlakunta | Designated Partner | 11 Apr 2019 | 7 Years 6 Months | Current |
| Lalith Mohan Nudurupati | Designated Partner | 11 Apr 2019 | 7 Years 6 Months | Current |
Charges & Borrowings of Axia Life Sciences LLP
Axia Life Sciences LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Axia Life Sciences LLP
Employment history and EPFO contributions of people linked to Axia Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Axia Life Sciences LLP
Axia Life Sciences LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Lalith Mohan Nudurupati was appointed as Designated Partner on 11 Apr 2019.
Credit Ratings, Litigation & Regulatory Alerts for Axia Life Sciences LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axia Life Sciences LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axia Life Sciences LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axia Life Sciences LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axia Life Sciences LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axia Life Sciences LLP
Axia Life Sciences is an active limited liability partnership based in Hyderabad, Telangana, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 11 April 2019 (7+ years old) and is registered under LLPIN AAO-8576.
Axia Life Sciences has 2 current designated partners:
- Vamshidhar Kandlakunta - Designated Partner
- Lalith Mohan Nudurupati - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Axia Life Sciences is AAO-8576. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Axia Life Sciences was incorporated on 11 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lalith Mohan Nudurupati was appointed as Designated Partner on 11 Apr 2019. Vamshidhar Kandlakunta was appointed as Designated Partner on 11 Apr 2019.
The registered office of Axia Life Sciences is at H. No. 1 – 2 – 104503 Evr Shradha Enclave Kakatiya Nagar Street No 2 Habsiguda, Hyderabad, Telangana, India – 500007.
The total obligation of contribution is ₹1 Lakh.
Axia Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Axia Life Sciences can be reached at its registered office: H. No. 1 – 2 – 104503 Evr Shradha Enclave Kakatiya Nagar Street No 2 Habsiguda, Hyderabad, Telangana, India – 500007.
Axia Life Sciences is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.